BioLib Technologies ApS: Financial statements 2022
CVR: 40705341
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BioLib Technologies ApS (CVR 40705341) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,149,958 and a net result of DKK 114,849 compared with DKK 183,350 the year before. That is an increase of 13.1% compared with the year before. Equity in the 2022 report amounted to DKK 425,485. The solvency ratio was 48.5%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 2,149,958
- Profit/Loss
- DKK 114,849
- Equity
- DKK 425,485
- Total Assets
- DKK 877,297
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2.1 mio. | 115 t. | 425 t. | 5 |
| 2021 | - | 1.9 mio. | 183 t. | 311 t. | 6 |
| 2020 | - | 1.5 mio. | -47 t. | 127 t. | 6 |
Official annual report
Keep an eye on BioLib Technologies ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioLib Technologies ApS has published its annual report for 2021. Gross profit came to DKK 1,901,454, and the net result was DKK 183,350.
About BioLib Technologies ApS
BioLib Technologies ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Anden udgivelse af software. The management consists of Jeppe Bjørn Hallgren and Mads Schovsbo Brøgger. The company is owned by BioLib, Inc.. According to the 2025 annual report, the company had an average of 9 employees. In 2025, the company reported a gross profit of DKK 10,881,630 and a net result of DKK 1,390,980 compared with DKK 1,638,857 the year before. Equity in the 2025 report amounted to DKK 4,698,792.